FIELD: medicine.
SUBSTANCE: method involves determining cortisol hormone concentration in cerebral metastasis-ill patient blood prior to treatment beginning. Its concentration being found within the limits of 54.0 to 130.0 nmole/l, metastatic lesion foci are predicted to be available in other internal organs and tissues.
EFFECT: high forecasting accuracy and information capacity.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING EXTRACRANIAL METASTASES DEVELOPMENT IN PATIENTS HAVING METASTASES IN BRAIN | 2005 |
|
RU2297005C1 |
| METHOD FOR PREDICTING CEREBRAL METASTASIS LESION FOCI IN METASTATIC BRAIN INJURY PATIENTS | 2005 |
|
RU2300109C2 |
| METHOD FOR TREATING ONCOLOGICAL PATIENTS WITH METASTATIC CEREBRAL LESION | 2005 |
|
RU2290974C1 |
| METHOD FOR PREDICTING RELAPSE OF MAMMARY CANCER | 2003 |
|
RU2263319C2 |
| METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH MAMMARY CANCER | 2003 |
|
RU2251692C2 |
| METHOD FOR PREDICTING METASTASIS AND FLOW OF TUMOR PROCESS IN PATIENTS WITH PULMONARY CANCER | 2002 |
|
RU2214605C1 |
| METHOD FOR TREATING CEREBRAL METASTASES OF GENERALIZED SKIN MELANOMA | 2005 |
|
RU2286146C1 |
| METHOD FOR PREDICTING EFFICIENCY OF AUTOHEMOCHEMOTHERAPY IN PATIENTS WITH CANCER OF MOUTH CAVITARY AND PHARYNGEAL ORGANS | 2003 |
|
RU2253354C2 |
| METHOD OF PREDICTING OF PROCESS ACTIVATION IN PATIENTS WITH HODGKIN'S LYMPHOMA | 2009 |
|
RU2405454C1 |
| METHOD OF PREDICTING CHEMORADIOTHERAPY EFFICIENCY IN PATIENTS WITH DISSEMINATED SKIN MELANOMA | 2008 |
|
RU2398238C1 |
